Dr. Wen-Han Chang, corresponding author, added, “The work highlights why biomarkers cannot be interpreted in isolation. Tumor context—immune composition, metabolic state, and innate ...

According to Mordor Intelligence, the healthcare IT market is valued at USD 413.14 billion in 2025, and is projected to ...

Cancer continues to be one of the most challenging diseases to treat worldwide. The three main methods used to treat cancer ...

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

Multi-omics analysis has emerged as a powerful approach in translational medicine, integrating diverse molecular data to ...

Trevolin Pillay, a proud member of the Deaf community, celebrates a remarkable achievement as he graduates with a BSc Honours ...

In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR ...

Through this partnership, Inotiv will integrate VUGENE’s cloud-based bioinformatics and computational platform into its Discovery & Translational Sciences Division, enabling a more efficient and ...

Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and ...

Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests. They ...

Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks ...

An upcoming conference in Bermuda will shape genomics research for the next 30 years. The Bermuda Principles 30th anniversary ...